Manifestaciones pulmonares de la artritis reumatoide, una revisión en tiempos de pandemia por SARS-CoV-2

Farquhar, 2019, Pulmonary complications of rheumatoid arthritis, Semin Respir Crit Care Med., 40, 194, 10.1055/s-0039-1683995 Amital, 2011, The lung in rheumatoid arthritis, Press Medicale., 40, 53, 10.1016/j.lpm.2010.11.003 Chatzidionisyou, 2016, The lung in rheumatoid arthritis, cause or consequence?, Curr Opin Rheumatol., 28, 76, 10.1097/BOR.0000000000000238 Alunno, 2017, Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis, Biomed Res Int., 2017, 10.1155/2017/7915340 Esposito, 2019, Thoracic manifestations of rheumatoid arthritis, Clin Chest Med., 40, 545, 10.1016/j.ccm.2019.05.003 Shaw, 2015, Rheumatoid arthritis-associated lung disease, Eur Respir Rev., 24, 1, 10.1183/09059180.00008014 Brito, 2017, Rheumatoid arthritis-associated interstitial lung disease: Current concepts, Curr Rheumatol Rep., 19, 79, 10.1007/s11926-017-0701-5 Duarte, 2019, The lung in a cohort of rheumatoid arthritis patients — an overview of different types of involvement and treatment, Rheumatology., 58, 2031, 10.1093/rheumatology/kez177 Kawano-dourado, 2020, Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis, Chest., 158, 1546, 10.1016/j.chest.2020.04.061 Raimundo, 2019, Rheumatoid arthritis — interstitial lung disease in the United States: Prevalence, incidence, and healthcare costs and mortality, J Rheumatol., 46, 218, 10.3899/jrheum.171315 Iqbal, 2015, Treatment of rheumatoid arthritis-associated interstitial lung disease: A perspective review, Ther Adv Musculoskelet Dis., 7, 247, 10.1177/1759720X15612250 Klareskog, 2006, A new model for an etiology of rheumatoid arthritis, Arthritis Rheum., 54, 38, 10.1002/art.21575 Dai, 2020, Rheumatoid arthritis-associated interstitial lung disease: An overview of epidemiology, pathogenesis and management, Clin Rheumatol. Castellanos-Gutiérrez MÁ, 2019, Manifestaciones pulmonares de artritis reumatoide: cor pulmonale, Rev Colomb Reumatol., 26, 129 Weng, 2015, Interstitial lung disease and rheumatoid arthritis: A review, Proc Singapore Healthc., 24, 35, 10.1177/201010581502400106 Sparks, 2016, The roles of cigarette smoking and the lung in the transitions between phases of preclinical rheumatoid arthritis, Curr Rheumatol Rep., 18, 2, 10.1007/s11926-016-0563-2 Turesson, 2013, Extra-articular rheumatoid arthritis, Curr Opin Rheumatol., 25, 360, 10.1097/BOR.0b013e32835f693f Othman, 2017, Anti-carbamylated protein antibodies in rheumatoid arthritis patients their association with rheumatoid factor, Saudi Med J., 38, 934, 10.15537/smj.2017.9.20841 Castellanos-Moreira, 2020, Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: Evidence of a new autoantibody linked to interstitial lung disease, Ann Rheum Dis., 79, 587, 10.1136/annrheumdis-2019-216709 Zhu, 2019, [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease], Beijing Da Xue Xue Bao Yi Xue Ban, 51, 1003 Zamora-Legoff, 2017, Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease, Arthritis Rheumatol., 69, 542, 10.1002/art.39971 Cassone, 2020, Treatment of rheumatoid arthritis-associated interstitial lung disease: Lights and shadows, J Clin Med., 9, 1, 10.3390/jcm9041082 O’Dwyer, 2013, Rheumatoid arthritis associated interstitial lung disease, Eur J Intern Med., 24, 597, 10.1016/j.ejim.2013.07.004 Martinez, 2014, Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis, N Engl J Med., 370, 2093, 10.1056/NEJMoa1401739 Dixon, 2012, Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case-control analysis, Ann Rheum Dis., 71, 1128, 10.1136/annrheumdis-2011-200702 Smolen, 2014, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Ann Rheum Dis., 73, 492, 10.1136/annrheumdis-2013-204573 Juge, 2020, Methotrexate and rheumatoid arthritis associated interstitial lung disease, Eur Respir J. Ibfelt, 2021, Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: A nationwide population-based study, Rheumatology., 60, 346, 10.1093/rheumatology/keaa327 Yusof, 2017, Effect of rituximab on the progression of rheumatoid arthritis related interstitial lung disease: 10 years’ experience at a single centre, Rheumatology., 56, 1348, 10.1093/rheumatology/kex072 Fernández-Díaz, 2018, Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients, Semin Arthritis Rheum., 48, 22, 10.1016/j.semarthrit.2017.12.012 Hallowell, 2014, Interstitial lung disease in patients with rheumatoid arthritis: Spontaneous and drug induced, Drugs., 74, 443, 10.1007/s40265-014-0190-z Koike, 2011, Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: Interim analysis of 3881 patients, Ann Rheum Dis., 70, 2148, 10.1136/ard.2011.151092 Wang, 2019, Mechanisms of lung disease development in rheumatoid arthritis, Nat Rev Rheumatol., 15, 581, 10.1038/s41584-019-0275-x Arrossi, 2019, Pulmonary pathology in rheumatic disease, Clin Chest Med., 40, 667, 10.1016/j.ccm.2019.05.011 Komarla, 2015, Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis, J Clin Rheumatol., 21, 211, 10.1097/RHU.0000000000000244 Corcoran, 2014, Pleuro-pulmonary complications of rheumatoid arthritis, Respir Care., 59, 55, 10.4187/respcare.02597 Simon, 2015, Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis, Arthritis Res Ther., 17, 212310, 10.1186/s13075-015-0728-9 Thakkar, 2016, Connective tissue disease-related pulmonary arterial hypertension, Best Pract Res Clin Rheumatol., 30, 22, 10.1016/j.berh.2016.03.004 Yang, 2013, Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: A systematic review of the literature, Clin Rheumatol., 32, 1519, 10.1007/s10067-013-2307-2 Montani, 2018, Association between rheumatoid arthritis and pulmonary hypertension: Data from the French pulmonary hypertension registry, Respiration., 95, 244, 10.1159/000485631 Massey, 2013, Thoracic complications of rheumatoid disease, Clin Radiol., 68, 293, 10.1016/j.crad.2012.07.007 Bacani, 2012, Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?, Arthritis Rheum., 64, 53, 10.1002/art.33322 Panagiotidou, 2017, Rheumatoid arthritis associated pulmonary hypertension: Clinical challenges reflecting the diversity of pathophysiology, Respir Med Case Reports., 20, 164 Aithala, 2017, Pulmonary hypertension in connective tissue diseases: An update, Int J Rheum Dis., 20, 5, 10.1111/1756-185X.13001 Tourin, 2013, Pulmonary vasculitis as the first manifestation of rheumatoid arthritis, Respir Med Case Reports., 8, 40 Berman, 2018, Emergent complications of rheumatoid arthritis, J Emerg Med., 55, 647, 10.1016/j.jemermed.2018.07.030 Greco, 2012, Cricoarytenoid joint involvement in rheumatoid arthritis: Radiologic evaluation, Am J Otolaryngol - Head Neck Med Surg., 33, 753 Mori, 2011, Small airway obstruction in patients with rheumatoid arthritis, Mod Rheumatol., 21, 164, 10.3109/s10165-010-0376-5 Wilczynska, 2013, Coexistence of bronchiectasis and rheumatoid arthritis: Revisited, Respir Care., 58, 694, 10.4187/respcare.01857 Rubbert-Roth, 2016, Lungenkarzinom und rheumatoide Arthritis: Eine interdisziplinäre Herausforderung, Z Rheumatol., 75, 47, 10.1007/s00393-016-0043-0 Chang, 2014, Smoking and rheumatoid arthritis, Int JX Mol Sci., 15, 22279, 10.3390/ijms151222279 England, 2016, Associations of circulating cytokines and chemokines with cancer mortality in men with rheumatoid arthritis, Arthritis Rheumatol., 68, 2394, 10.1002/art.39735 Zhang, 2020, Lung cancer in patients with and without rheumatoid arthritis: A propensity score-matched survival analysis cohort study, Thorac Cancer., 11, 1406, 10.1111/1759-7714.13388 Akata, 2012, Bacteriological analysis of lower respiratory tract in patients with rheumatoid arthritis and other collagen vascular diseases, Eur Respir J., 40, 2493 Sebastiani, 2017, Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients, Clin Exp Rheumatol., 35, 542 Singh, 2016, 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis, Arthritis Care Res., 68, 1, 10.1002/acr.22783 Wasserman, 2018, Rheumatoid arthritis: Common questions about diagnosis and management, Am Fam Physician., 97, 455 Liao, 2015, Risk for mycobacterial disease among patients with rheumatoid arthritis Taiwan, 2001-2011, Emerg Infect Dis., 21, 1387, 10.3201/eid2108.141846 Singh, 2011, Adverse effects of biologics: A network meta-analysis and Cochrane overview, Cochrane Database Syst Rev., 1 Handa, 2017, Tuberculosis and biologics in rheumatology: A special situation, Int J Rheum Dis., 20, 1313, 10.1111/1756-185X.13129 Cantini, 2014, Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-a (TNF-a) targeted biologics and recently licensed TNF-a inhibitors: Data from clinical trials and national registries, J Rheumatol., 41, 56 Winthrop, 2016, Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis, Ann Rheum Dis., 75, 1133, 10.1136/annrheumdis-2015-207319 Cantini, 2017, Risk of tuberculosis reactivation in patients with rheumatoid arthritis ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics, Hindawi Mediat Inflamm., 2017, 8909834 Buch, 2011, Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis, Ann Rheum Dis., 70, 909, 10.1136/ard.2010.144998 Talotta, 2020, Autoimmunity as the comet tail of COVID-19 pandemic, World J Clin Cases., 8, 3621, 10.12998/wjcc.v8.i17.3621 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study, Lancet Respir., 8, 475, 10.1016/S2213-2600(20)30079-5 Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol., 20, 363, 10.1038/s41577-020-0311-8 Cheng, 2020, COVID-19 with rheumatic diseases: A report of 5 cases, Clin Rheumatol., 39, 2025, 10.1007/s10067-020-05160-x Favalli, 2020, COVID-19 infection and rheumatoid arthritis: Faraway, so close!, Autoimmun Rev., 19, 102523, 10.1016/j.autrev.2020.102523 Bin, 2019, Respiratory viral infections and the risk of rheumatoid arthritis, Arthritis Res Ther., 21, 199208 Gianfrancesco, 2020, Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician reported registry, Ann Rheum Dis., 79, 859, 10.1136/annrheumdis-2020-217871 Ceribelli, 2020, Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy, J Autoimmun., 109, 10.1016/j.jaut.2020.102442 Xu, 2020, Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2, J Infect., 80, 394, 10.1016/j.jinf.2020.02.017 Jin, 2020, A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version), Mil Med Res., 7, 4 Sánchez-oro, 2020, La radiología en el diagnóstico de la neumonía por SARS-CoV-2 (COVID-19), Med Clin., 155, 36, 10.1016/j.medcli.2020.03.004 Hsieh, 2018, Recovery of pulmonary functions exercise capacity and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis, Influenza Other Respir Viruses., 12, 643, 10.1111/irv.12566 Ye, 2020, Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China, Ann Rheum Dis., 79, 1007, 10.1136/annrheumdis-2020-217627 Vitiello, 2020, COVID-19 patients with pulmonary fibrotic tissue: Clinical pharmacological rational of antifibrotic therapy, SN Compr Clin Med., 1 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet., 395, 507, 10.1016/S0140-6736(20)30211-7 Roongta, 2020, Managing rheumatoid arthritis during COVID-19, Clin Rheumatol., 39, 3237, 10.1007/s10067-020-05358-z Song, 2020, Coronavirus disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs, Rheumatol Int., 40, 991, 10.1007/s00296-020-04584-7 Mikuls, 2020, American College of Rheumatology Guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic: Version 2, Arthritis Rheumatol., 72, e1